Ontamalimab is a highly specialized fully human monoclonal antibody target mucosal addressin cell adhesion molecule-1 (MAdCAM-1), inhibition of lymphocyte homing to the gastrointestinal mucosa by disrupting the interaction between MAdCAM-1 and the alpha 4 beta 7 integrin across various inflammatory models.
Purity:
95.00%
CAS Number:
[2098790-40-8]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted